Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil

References

1. Centers for Disease Control and Prevention ( 1996;). Prevention of perinatal group B streptococcal disease: a public health perspective. Morb Mortal Wkly Rep 45 (RR-7), 1–24.
   [Google Scholar]
2. de Azavedo, J. C. S., McGavin, M., Duncan, C., Low, D. E. & McGeer, A. ( 2001;). Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 45, 3504–3508.[CrossRef]
   [Google Scholar]
3. d'Oliveira, R. E. C., Barros, R. R., Mendonça, C. R. V., Teixeira, L. M. & Castro, A. C. D. ( 2003;). Antimicrobial susceptibility and survey of macrolide resistance mechanisms among Streptococcus pyogenes isolated in Rio de Janeiro, Brazil. Microb Drug Resist 9, 87–91.[CrossRef]
   [Google Scholar]
4. Fernandez, M., Hickman, M. E. & Baker, C. J. ( 1998;). Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 42, 1517–1519.
   [Google Scholar]
5. Hsueh, P.-R., Teng, L.-J., Lee, L.-N., Ho, S.-W., Yang, P.-C. & Luh, K.-T. ( 2001;). High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother 45, 3205–3208.[CrossRef]
   [Google Scholar]
6. Muñoz, P., Llancaqueo, A., Rodríguez-Créixems, M., Peláez, T., Martin, L. & Bouza, E. ( 1997;). Group B streptococcus bacteremia in nonpregnant adults. Arch Intern Med 157, 213–216.[CrossRef]
   [Google Scholar]
7. National Committee for Clinical Laboratory Standards ( 2000a;). Performance Standards for Antimicrobial Disk Susceptibility Tests, 7th edn. Approved standard M2-A7. Wayne, PA: NCCLS.
8. National Committee for Clinical Laboratory Standards ( 2000b;). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th edn. Approved standard M7-A5. Wayne, PA: NCCLS.
9. Seppälä, H., Nissinen, A., Yu, Q. & Huovinen, P. ( 1993;). Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32, 885–891.[CrossRef]
   [Google Scholar]
10. Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C. & Huovinen, P. ( 1998;). A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 42, 257–262.[CrossRef]
    [Google Scholar]
11. Sutcliffe, J., Grebe, T., Tait-Kamradt, A. & Wondrack, L. ( 1996;). Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40, 2562–2566.
    [Google Scholar]
12. Traub, W. H. & Leonhard, B. ( 1997;). Comparative susceptibility of clinical group A, B, C, F, and G β-hemolytic streptococcal isolates to 24 antimicrobial drugs. Chemotherapy 43, 10–20.[CrossRef]
    [Google Scholar]